BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 2497283)

  • 1. HLA-DR and DQ antigens in chronic lymphocytic leukemia: dissociation of expression revealed by cell surface, protein, and mRNA studies.
    Kraïba R; Loiseau P; Faille A; Poirier O; Piatier-Tonneau D; Degos L; Abita JP; Charron D
    Leukemia; 1989 May; 3(5):386-93. PubMed ID: 2497283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of MHC class II antigens in human B-cell leukaemia, and increased levels of class II antigens and DR-specific mRNA after stimulation with 12-O-tetradecanoyl phorbol-13-acetate.
    Guy K; Meehan RR; Dewar AE; Larhammar D
    Immunology; 1986 Feb; 57(2):181-8. PubMed ID: 3512424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of gamma interferon on HLA class-I and -II transcription and protein expression in human breast adenocarcinoma cell lines.
    Jabrane-Ferrat N; Faille A; Loiseau P; Poirier O; Charron D; Calvo F
    Int J Cancer; 1990 Jun; 45(6):1169-76. PubMed ID: 2112515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of genes for HLA class II antigens in cell lines from patients with severe combined immunodeficiency.
    de Préval C; Hadam MR; Mach B
    N Engl J Med; 1988 May; 318(20):1295-300. PubMed ID: 3129659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential susceptibility to recombinant interferon-gamma-induced HLA-DQ antigen modulation among clones from a human metastatic melanoma.
    Anichini A; Castelli C; Sozzi G; Fossati G; Parmiani G
    J Immunol; 1988 Jan; 140(1):183-91. PubMed ID: 3121738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of MHC class II molecules HLA-DR, -DP and -DQ and ICAM 1 in human podocytes by gamma-interferon.
    Baudeau C; Delarue F; Hé CJ; Nguyen G; Adida C; Peraldi MN; Sraer JD; Rondeau E
    Exp Nephrol; 1994; 2(5):306-12. PubMed ID: 7812737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential surface expression of class II isotypes on activated CD4 and CD8 cells correlates with levels of locus-specific mRNA.
    Diedrichs M; Schendel DJ
    J Immunol; 1989 May; 142(9):3275-80. PubMed ID: 2785139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HLA DR, DQ, and DP antigen expression in rheumatoid synovial cells: a biochemical and quantitative study.
    Teyton L; Lotteau V; Turmel P; Arenzana-Seisdedos F; Virelizier JL; Pujol JP; Loyau G; Piatier-Tonneau D; Auffray C; Charron DJ
    J Immunol; 1987 Mar; 138(6):1730-8. PubMed ID: 3102596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential presentation of HLA-DR, DQ, and DP restriction elements by interferon-gamma-treated dermal fibroblasts.
    Maurer DH; Hanke JH; Mickelson E; Rich RR; Pollack MS
    J Immunol; 1987 Aug; 139(3):715-23. PubMed ID: 3110281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autologous B lymphoblastoid cell lines and long-term cultured T cells as stimulators in the mixed lymphocyte reaction: analysis of the role of HLA class II antigens as stimulatory molecules.
    Santoli D; Radka SF; Igarashi M; Kreider BL; Ferrone S
    J Immunol; 1986 Jul; 137(2):400-7. PubMed ID: 2941479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T cells specific for different antigens express different HLA-D region products.
    Schendel DJ; Johnson JP
    Eur J Immunol; 1985 Dec; 15(12):1239-43. PubMed ID: 3878791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of aberrant transcription of major histocompatibility complex class II antigen presentation genes in chronic lymphocytic leukaemia identifies HLA-DOA mRNA as a prognostic factor for survival.
    Souwer Y; Chamuleau ME; van de Loosdrecht AA; Tolosa E; Jorritsma T; Muris JJ; Dinnissen-van Poppel MJ; Snel SN; van de Corput L; Ossenkoppele GJ; Meijer CJ; Neefjes JJ; Marieke van Ham S
    Br J Haematol; 2009 May; 145(3):334-43. PubMed ID: 19245431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two distinct class II molecules encoded by the genes within HLA-DR subregion of HLA-Dw2 and Dw12 can act as stimulating and restriction molecules.
    Sone T; Tsukamoto K; Hirayama K; Nishimura Y; Takenouchi T; Aizawa M; Sasazuki T
    J Immunol; 1985 Aug; 135(2):1288-98. PubMed ID: 3159789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression and function of class II antigens on gastric carcinoma cells and gastric epithelia: differential expression of DR, DQ, and DP antigens.
    Sakai K; Takiguchi M; Mori S; Kobori O; Morioka Y; Inoko H; Sekiguchi M; Kano K
    J Natl Cancer Inst; 1987 Nov; 79(5):923-32. PubMed ID: 2960847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Analysis of HLA-class II antigen mRNAs on T lymphoblasts].
    Tate G; Katagiri M
    Hokkaido Igaku Zasshi; 1986 Mar; 61(2):249-56. PubMed ID: 3487495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monoclonal antibodies to HLA-DP, DQ, and DR determinants: functional effects on the activation and proliferation of normal and EBV-transformed B cells.
    Howard DR; Eaves AC; Takei F
    Exp Hematol; 1986 Oct; 14(9):887-95. PubMed ID: 2428652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence for a specific post-transcriptional mechanism controlling the expression of HLA-DQ, but not -DR and -DP, molecules.
    De Lerma Barbaro A; Sartoris S; Tosi G; Nicolis M; Accolla RS
    J Immunol; 1994 Nov; 153(10):4530-8. PubMed ID: 7525708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential expression of Ia antigens by rheumatoid synovial lining cells.
    Burmester GR; Jahn B; Rohwer P; Zacher J; Winchester RJ; Kalden JR
    J Clin Invest; 1987 Sep; 80(3):595-604. PubMed ID: 2442194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HLA class II molecules (HLA-DR, -DP, -DQ) on cells in the human CNS studied in situ and in vitro.
    Ulvestad E; Williams K; Bø L; Trapp B; Antel J; Mørk S
    Immunology; 1994 Aug; 82(4):535-41. PubMed ID: 7835916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discoordinate surface expression of IFN-gamma-induced HLA class II proteins in nonprofessional antigen-presenting cells with absence of DM and class II colocalization.
    Muczynski KA; Anderson SK; Pious D
    J Immunol; 1998 Apr; 160(7):3207-16. PubMed ID: 9531276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.